Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of a novel microRNA profile in pediatric patients with cancer treated with anthracycline chemotherapy

24 Aug 2018

Abstract excerpt

Anthracycline chemotherapy (AC) is associated with decline in left ventricular ejection fraction (LVEF), yet the mechanisms remain unclear. Although changes in microRNAs (miRs) have been identified in adult cardiovascular disease, miR profiles in pediatric patients with AC have not been well studied. The goal of this study was to examine miR profiles (unbiased array) in pediatric patients with AC compared with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chemotherapy-induced cardiotoxicity and mitigation
Share to Chemotherapy-induced organ toxicity mitigation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30141982
DOI: 10.1152/ajpheart.00252.2018

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of a novel microRNA profile in pediatric patients with cancer treated with anthracycline chemotherapyPMID 30141982Read ↗

Circulating MicroRNA as Biomarkers of Anthracycline-Induced CardiotoxicitySemantic proximity Read ↗

Altered Peripheral Blood Gene Expression in Childhood Cancer Survivors With Anthracycline‐Induced Cardiomyopathy – A COG‐ALTE03N1 ReportSemantic proximity Read ↗

Circulating microRNA as a biomarker for recovery in pediatric dilated cardiomyopathySemantic proximity Read ↗

Modeling Cardiotoxicity in Pediatric Oncology Patients Using Patient-Specific iPSC-Derived Cardiomyocytes Reveals Downregulation of Cardioprotective microRNAsSemantic proximity Read ↗

Prognostic Factors for Cardiotoxicity Among Children With Cancer: Definition, Causes and Diagnosis With Omics TechnologiesSemantic proximity Read ↗

Age-dependent Transcriptional Programs Distinguish Pediatric from Adult Dilated CardiomyopathySemantic proximity Read ↗

MicroRNAs in anthracycline cardiotoxicity: biomarkers, mechanisms, and therapeutic advancesSemantic proximity Read ↗

Pediatric dilated cardiomyopathy hearts display a unique gene expression profileSemantic proximity Read ↗

Pediatric and adult dilated cardiomyopathy are distinguished by distinct biomarker profiles.Semantic proximity Read ↗

Predicting the 10-year risk of cardiomyopathy in long-term survivors of childhood cancer: a report from the St. Jude Lifetime Cohort and the Childhood Cancer Survivor StudySemantic proximity Read ↗

Clinical prediction models for anthracycline-associated cardiotoxicity among pediatric cancer survivors--ready for prime time?Semantic proximity Read ↗

miRNA expression in pediatric failing human heartSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.